To address the potential impact of chemotherapeutic drugs on immune responses to NB, we chose two syngeneic mouse tumor models, 975A2 and 9464D, derived from spontaneous NB arising in TH-MYCN transgenic mice on C57BL/6 background [27]. The gene discussed is MYCN; the disease is neuroblastoma.